AVIR
NASDAQ · Pharmaceuticals
Atea Pharmaceuticals Inc
$4.21
-0.01 (-0.24%)
Open$4.20
Previous Close$4.22
Day High$4.22
Day Low$4.19
52W High$6.45
52W Low$2.87
Volume—
Avg Volume298.9K
Market Cap345.68M
P/E Ratio—
EPS$-2.09
SectorPharmaceuticals
Analyst Ratings
Strong Buy
9 analysts
Price Target
+993.8% upside
Current
$4.21
$4.21
Target
$46.05
$46.05
$31.54
$46.05 avg
$64.23
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 49.99M | 49.26M | 44.69M |
| Net Income | 8.60M | 11.50M | 7.45M |
| Profit Margin | 17.2% | 23.3% | 16.7% |
| EBITDA | 12.90M | 12.92M | 13.20M |
| Free Cash Flow | 9.03M | 8.66M | 6.93M |
| Rev Growth | +19.5% | +7.9% | +2.0% |
| Debt/Equity | 0.36 | 0.36 | 0.32 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,354.00 | -0.79% | 46.6 | 1.28T |
| JNJ | Johnson & Johnson | $276.22 | +1.43% | 40.8 | 656.45B |
| MRK | Merck & Co. Inc. | $146.73 | -0.14% | 147.8 | 362.53B |
| PFE | Pfizer Inc. | $29.39 | -1.64% | 41.4 | 167.12B |
| BMY | Bristol-Myers Squibb Co | $62.14 | -1.57% | 13.8 | 127.96B |
| ZTS | Zoetis Inc | $79.40 | -3.30% | 12.8 | 33.59B |